| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
45,766,000 |
| Market
Cap: |
810.52(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$6.29 - $46.14 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8 |
| Insider 6 Months : 8 |
| Insider 3/6 Months : 16.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
11,700 |
11,700 |
11,700 |
11,700 |
| Total Buy Value |
$198,783 |
$198,783 |
$198,783 |
$198,783 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
27,257 |
27,913 |
50,523 |
602,067 |
| Total Sell Value |
$483,218 |
$487,552 |
$1,177,752 |
$28,445,866 |
| Total People Sold |
5 |
5 |
6 |
8 |
| Total Sell Transactions |
6 |
7 |
15 |
58 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Weatherman Elizabeth H |
|
– • – |
2023-03-15 |
4 |
AS |
$41.91 |
$209,550 |
D/D |
(5,000) |
149,454 |
|
-48% |
|
| Jones Marie L. |
CAO and VP, Finance |
• – – |
2023-03-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,496 |
|
-54% |
|
| Ruedy Richard |
EVPClin&Reg.Affairs&QA |
• – – |
2023-03-06 |
4 |
S |
$47.73 |
$113,257 |
D/D |
(2,373) |
145,483 |
|
54% |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2023-03-06 |
4 |
S |
$47.74 |
$184,653 |
D/D |
(3,868) |
115,683 |
|
54% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2023-03-03 |
4 |
S |
$47.10 |
$849,901 |
D/D |
(18,043) |
269,132 |
|
54% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2023-03-03 |
4 |
S |
$47.11 |
$467,193 |
D/D |
(9,918) |
205,575 |
|
54% |
|
| Ruedy Richard |
EVPClin&Reg.Affairs&QA |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,341 |
147,856 |
|
- |
|
| Klemz Kevin M |
EVP/Chief Legal Officer/Sec. |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
20,011 |
40,336 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
40,976 |
287,175 |
|
- |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
26,682 |
215,493 |
|
- |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
21,346 |
119,551 |
|
- |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2023-03-01 |
4 |
AS |
$48.02 |
$324,272 |
D/D |
(6,753) |
98,205 |
|
-32% |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2023-03-01 |
4 |
OE |
$4.73 |
$31,942 |
D/D |
6,753 |
99,019 |
|
- |
|
| Weatherman Elizabeth H |
|
– • – |
2023-02-15 |
4 |
AS |
$49.86 |
$249,300 |
D/D |
(5,000) |
154,454 |
|
-36% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2023-02-13 |
4 |
AS |
$50.94 |
$305,627 |
D/D |
(6,000) |
246,199 |
|
-34% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2023-02-13 |
4 |
OE |
$1.60 |
$9,600 |
D/D |
6,000 |
252,199 |
|
- |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2023-02-01 |
4 |
AS |
$54.05 |
$365,000 |
D/D |
(6,753) |
98,205 |
|
-42% |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2023-02-01 |
4 |
OE |
$4.73 |
$31,942 |
D/D |
6,753 |
104,958 |
|
- |
|
| Chou Tony M. |
|
– • – |
2023-02-01 |
4 |
AS |
$55.00 |
$715,440 |
D/D |
(13,008) |
75,707 |
|
-42% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2023-01-19 |
4 |
AS |
$53.40 |
$2,202,533 |
D/D |
(41,244) |
188,811 |
|
-43% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2023-01-19 |
4 |
OE |
$1.60 |
$535,666 |
D/D |
38,528 |
217,289 |
|
- |
|
| Weatherman Elizabeth H |
|
– • – |
2023-01-17 |
4 |
AS |
$54.69 |
$3,082,224 |
D/D |
(56,355) |
159,454 |
|
-45% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2023-01-17 |
4 |
AS |
$54.68 |
$2,460,623 |
D/D |
(45,000) |
191,527 |
|
-45% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2023-01-17 |
4 |
OE |
$1.60 |
$72,000 |
D/D |
45,000 |
236,527 |
|
- |
|
| Chou Tony M. |
|
– • – |
2023-01-13 |
4 |
AS |
$55.00 |
$44,330 |
D/D |
(806) |
87,709 |
|
-44% |
|
169 Records found
|
|
Page 1 of 7 |
|
|
0.34 (1.88%) 
